N
Neil MacDonald
Researcher at McGill University
Publications - 67
Citations - 7970
Neil MacDonald is an academic researcher from McGill University. The author has contributed to research in topics: Palliative care & Cancer. The author has an hindex of 26, co-authored 65 publications receiving 6373 citations.
Papers
More filters
Journal ArticleDOI
Definition and classification of cancer cachexia: an international consensus
Kenneth C. H. Fearon,Florian Strasser,Stefan D. Anker,Ingvar Bosaeus,Eduardo Bruera,Robin L. Fainsinger,Aminah Jatoi,Charles L. Loprinzi,Neil MacDonald,Giovanni Mantovani,Mellar P. Davis,Maurizio Muscaritoli,Faith D. Ottery,Lukas Radbruch,Paula Ravasco,Declan Walsh,Andrew Wilcock,Stein Kaasa,Vickie E. Baracos +18 more
TL;DR: A framework exists on a framework for the definition and classification of cancer cachexia, a multifactorial syndrome defined by an ongoing loss of skeletal muscle mass that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment.
Journal ArticleDOI
Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.
Lisa Martin,Laura Birdsell,Neil MacDonald,Tony Reiman,M. Thomas Clandinin,Linda J. McCargar,Rachel A. Murphy,Sunita Ghosh,Michael B. Sawyer,Vickie E. Baracos +9 more
TL;DR: Patients with cancer who are cachexic by the conventional criterion and by two additional criteria (muscle depletion and low muscle attenuation) share a poor prognosis, regardless of overall body weight.
Journal ArticleDOI
Nutritional Recommendations for the Management of Sarcopenia
John E. Morley,Josep M. Argilés,William J. Evans,Shalender Bhasin,David Cella,Nicolaas E. P. Deutz,Wolfram Doehner,Kenneth C. H. Fearon,Luigi Ferrucci,Marc K. Hellerstein,Kamyar Kalantar-Zadeh,H. Lochs,Neil MacDonald,Kathleen Mulligan,Maurizio Muscaritoli,Piotr Ponikowski,Mary Ellen Posthauer,Filippo Rossi Fanelli,Morrie Schambelan,Annemie M. W. J. Schols,Michael W. Schuster,Stefan D. Anker +21 more
TL;DR: The Society for Sarcopenia, Cachexia, and Wasting Disease convened an expert panel to develop nutritional recommendations for prevention and management of sarcopenia.
Journal ArticleDOI
An Eicosapentaenoic Acid Supplement Versus Megestrol Acetate Versus Both for Patients With Cancer-Associated Wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort
Aminah Jatoi,Kendrith M. Rowland,Charles L. Loprinzi,Jeff A. Sloan,Shaker R. Dakhil,Neil MacDonald,Bruno Gagnon,Paul J. Novotny,James A. Mailliard,Teresita I L Bushey,Suresh G. Nair Md,Brad Christensen +11 more
TL;DR: This EPA supplement, either alone or in combination with MA, does not improve weight or appetite better than MA alone and global quality of life was not significantly different among groups.
Journal ArticleDOI
Understanding and managing cancer cachexia
TL;DR: Mrs MJ is a 56-year-old architect with a husband and two children who developed widespread disease with metastases to liver, lung, and bone and is currently on antiestrogen therapy.